Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,330
datasets available to search
ShareScore release 0.9.0
Dataset results
4,330 results for “Melanoma”
Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer
ClinicalTrials.gov study NCT00328861. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in
ClinicalTrials.gov study NCT01319565. IPD Sharing: YES. Countries: 1. Publications: 6.
A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
ClinicalTrials.gov study NCT02570308. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
ClinicalTrials.gov study NCT00636168. IPD Sharing: Not stated. Countries: 19. Publications: 5.
A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )
ClinicalTrials.gov study NCT01227551. IPD Sharing: NO. Countries: 1. Publications: 1.
PVSRIPO for Patients With Unresectable Melanoma
ClinicalTrials.gov study NCT03712358. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma
ClinicalTrials.gov study NCT01970358. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma
ClinicalTrials.gov study NCT02714218. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT00700882. IPD Sharing: YES. Countries: 1. Publications: 2.
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02521870. IPD Sharing: YES. Countries: 4. Publications: 1.
Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
ClinicalTrials.gov study NCT01369888. IPD Sharing: Not stated. Countries: 1. Publications: 3.
SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma
ClinicalTrials.gov study NCT00577382. IPD Sharing: NO. Countries: 1. Publications: 1.
Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
ClinicalTrials.gov study NCT00387751. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma
ClinicalTrials.gov study NCT00145158. IPD Sharing: NO. Countries: 1. Publications: 3.
Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma
ClinicalTrials.gov study NCT04720417. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma
ClinicalTrials.gov study NCT01910181. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma
ClinicalTrials.gov study NCT01496807. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention
ClinicalTrials.gov study NCT03817125. IPD Sharing: NO. Countries: 1. Publications: 32.
Trametinib With GSK2141795 in BRAF Wild-type Melanoma
ClinicalTrials.gov study NCT01941927. IPD Sharing: NO. Countries: 1. Publications: 1.
Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients
ClinicalTrials.gov study NCT01308294. IPD Sharing: Not stated. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.